ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $690,501 | -83.8% | 7,374 | -84.5% | 0.00% | -87.5% |
| Q2 2023 | $4,250,619 | -26.9% | 47,626 | -12.1% | 0.01% | -27.3% |
| Q1 2023 | $5,811,644 | -19.3% | 54,203 | -8.1% | 0.01% | -26.7% |
| Q4 2022 | $7,201,150 | +5.4% | 58,963 | -10.9% | 0.02% | 0.0% |
| Q3 2022 | $6,834,000 | +49.4% | 66,202 | +34.5% | 0.02% | +66.7% |
| Q2 2022 | $4,575,000 | +6.0% | 49,232 | +33.8% | 0.01% | +12.5% |
| Q1 2022 | $4,316,000 | +21.3% | 36,785 | +39.1% | 0.01% | +33.3% |
| Q4 2021 | $3,557,000 | -12.3% | 26,453 | +3.9% | 0.01% | -14.3% |
| Q3 2021 | $4,056,000 | +52.4% | 25,455 | +25.8% | 0.01% | +75.0% |
| Q2 2021 | $2,662,000 | – | 20,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |